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doi:10.1016/j.jmii.2011.01.029Background: Non-polio enteroviruses may cause different diseases, including herpangina,
handefootemouth disease (HFMD), meningitis, and nonspecific febrile illness; and cause
epidemic outbreak annually. This study delineates the diversity of clinical presentations based
on different serotypes and different groups [human enterovirus (HEV)-A and HEV-B] of entero-
viruses (EVs) during the 2008 epidemic in National Taiwan University Hospital (NTUH).
Methods: We retrospectively identified patients younger than 18 years who had positive
isolates of non-polio EV in throat swabs, rectal swabs, or cerebrospinal fluid, in NTUH from
January 1 to December 31, 2008. For serotyping, immunofluorescence assay and polymerase
chain reaction followed by viral structure protein-1 sequencing were applied. We analyzed
and compared their clinical features among different serotypes and different groups of EVs.
Results: Among 172 patients who were enrolled, 16 serotypes were identified. The major
serotype in NTUH was EV71 (25.6%) followed by coxsackievirus A (CA)16 and coxsackievirus
B (CB)4. EV71 manifested mostly as HFMD (89%) and was complicated with encephalomyelitis
in three patients. Serotypes of HFMD included EV71 (70%), CA16 (27%), CA4, and CA6. Sero-
types of herpangina were heterogeneous, and the major serotype was CA2 (35.7%) followed
by CB4 (23.8%). Aseptic meningitis was entirely caused by HEV-B and mostly infected by
echovirus 30 (50%). Among children with EV-related respiratory tract infection, CB4 (32%)
was dominant in upper respiratory tract infection, whereas echovirus 4 (71%) was the majorfectious Diseases, Department of Pediatrics, National Taiwan University Hospital, 8 Chung-Shan South
u.tw, ly7077@tpts6.seed.net.tw (L.-Y. Chang).
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266 C.-H. Hsu et al.cause of lower respiratory tract infection. Cases of HEV-A were significantly younger than the
cases of HEV-B (pZ 0.04). Multivariate analysis revealed that the most significant factor
associated with hospitalization is HEV-B (odds ratio, 2.2; 95% confidence interval, 1.1e4.2;
pZ 0.02).
Conclusions: At least 16 serotypes circulated in northern Taiwan in 2008. EV71 is the
predominant strain in this outbreak. All patients with HFMD were infected by HEV-A, but
HEV-B was associated with a higher rate of hospitalization and aseptic meningitis, which
should be a cause of alert regarding public health.
Copyright ª 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Human enteroviruses (HEVs) are RNA viruses that belong to
the family Picornaviridae. HEVs were originally classified as
poliovirus (P), coxsackievirus A (CA), coxsackievirus B (CB),
or echovirus (Echo), based on their associated pathogenic-
ities. Since 1990s, a new classification of HEVs has been
developed based on their molecular characterization,
according to which HEVs are subgrouped into poliovirus,
HEV-A, HEV-B, HEV-C, and HEV-D, based on the similarities
in their viral structure protein (VP) genes.1
Those non-polio enteroviruses (NPEVs) may cause
different clinical manifestations, including herpangina,
handefootemouth disease (HFMD), meningitis, and
nonspecific febrile illness, and they often cause epidemic
outbreaks annually in certain countries, such as Taiwan.
During 1998e2005, CA16 and EV71 were the predominant
serotypes in Taiwan. Each of these serotypes account for
23% of reports associated with an identified serotype fol-
lowed by CB3 (13%), Echo4 (6%), CB4 (5%), and Echo6 (5%).
EV71 was more frequently isolated from patients with
encephalitis and pulmonary edema hemorrhage. Enterovi-
ruses (EVs) other than EV71 were more frequently isolated
when the complication was aseptic meningitis.2 In early
2008, an epidemic alert was declared by the Center for
Disease Control (CDC), Taiwan because of an increasing
number of cases. The final number of confirmed severe
cases were 373 subjects in 2008, which is much higher than
the case number in 2006 (11 subjects) and 2007 (12
subjects).3 The purpose of this study was to try to assess
the diversity of clinical presentations based on different
serotypes and different groups of EVs during the 2008
epidemic in National Taiwan University Hospital, a medical
center in northern Taiwan.Methods
Patients
We retrospectively identified patients younger than 18
years who had positive isolates of NPEVs from throat swabs,
rectal swabs, or cerebrospinal fluid (CSF), in National
Taiwan University Hospital (NTUH) from January 1 to
December 31, 2008. NTUH is a medical center serving
approximately 2,700 inpatients and 7,500 outpatients daily
in northern Taiwan.Data collection
The medical records of these patients were reviewed for
data, including age, sex, diagnosis, laboratory results, EV
serotype, hospitalization, complications, and neurologic
sequelae. Questionnaires were mailed to the patients who
visited the emergency department only. The questionnaires
included questions regarding the patient’s hospitalization
to other hospitals after visiting NTUH emergency depart-
ment. We arranged phone contact 2 weeks later if those
patients did not reply the mail. Patients with incomplete
clinical or virological data were excluded. We analyzed and
compared age, sex, diagnosis, and hospitalization, among
different serotypes and different groups of EVs.
Clinical definitions
The diagnosis was categorized as HFMD, herpangina, aseptic
meningitis, febrile illness, viral exanthema, upper airway
infection, and lower airway infection. Nonspecific illnesses
included febrile illness, viral exanthem, upper respiratory
tract infection (URI), and lower respiratory tract infection
(LRI). HFMD was defined as a typical rash over palms, soles,
buttocks, knees, or elbows. Herpangina was defined as the
presentation of pharyngeal ulcers without gingival swelling
or typical rashes from HFMD. Aseptic meningitis should
present meningism and pleocytosis (> 5 leukocyte/mm3 in
patients older than 1 month or > 25 leukocytes/mm3 in
neonates) in CSF and negative bacterial cultures. Encepha-
litis was diagnosed by disturbance of the consciousness, such
as lethargy, drowsiness, or coma, with characteristic slow
wave on electroencephalography. Poliomyelitis-like
syndromehad the characteristic of acute limbweaknesswith
diminished reflexes and muscular strength. A diagnosis of
encephalomyelitis was made when there was evidence of
encephalitis and poliomyelitis-like syndrome or an evident
white-matter change on magnetic resonance imaging. Viral
exanthem was defined as non-itching maculopapular rash.
URI included nasopharyngitis, laryngotrachitis, and tonsil-
litis. LRI presented as acute bronchitis, bronchiolitis, bron-
chopneumonia, or pneumonia.
Virus isolation and serotyping
Clinical samples were inoculated into human embryonic
fibroblast (MRC-5), rhesus monkey kidney (LLC-MK2),
laryngeal carcinoma (HEp-2), and RD cell cultures. When
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monolayer, the cell was scraped. Indirect immunofluores-
cent antibody staining with pan-enteroviral antibody
(Chemicon International, Inc., Temecula, CA, USA) and the
serotype-specific antibody for EV71; CA Types 9, 16, 24; CB
Types 1e6; and Echo Types 4, 6, 9, 11, 30, were used for
serotyping. If the serotype of the samples were not iden-
tified with indirect immunofluorescent antibody, poly-
merase chain reaction (PCR) followed by direct sequencing
was performed. Three genogroup-specific degenerate
oligonucleotide primers flanking the VP1 region were made,
including EntAF TNCARGCWGCNGARACNGG, EntAR outer
ANGGRTTNGTNGMWGTYTGCCA, EntAR inner GGNGGNA
CRWACATRTAYTG, EntBF GCNGYNGARACNGGNCACAC,
EntBR outer CTNGGRTTNGTNGANGWYTGCC, EntBR inner
CCNCCNGGBGGNAYRTACAT, EntCF TNACNGCNGTNGANA
CHGG, EntCR outer TGCCANGTRTANTCRTCCC, and EntCR
inner GCNCCWGGDGGNAYRTACAT. Amplicons of PCR with
three sets of VP1-specific primers were purified using the
Gel/PCR DNA Fragments Extraction Kit (Geneaid, Sijhih
City,Taipei County, Taiwan) before sequencing, and direct187 patients with 208 entero
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Figure 1. Flowchart of the enrolled patients and their sero
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specific PCRs. All methods were carried out following the
manufacturers’ instructions. A specific serotype was
defined when the VP1 amino acid sequence showed 88%
homology to the VP1 amino acid sequence of the specific
type of the HEV prototype strains.4
EVs were divided into four groups: CA Types 2e8, 10, 12,
14, 16, and EV71 belonged to HEV-A; all CB types (1e6); all
Echos (Types 1e9, 11e21, 24e27, and 29e33); CA9; and
EV69 were grouped as HEV-B; HEV-C comprised CA Types 1,
11, 13, 15, 17, 18, 20e22, 24, and polioviruses 1e3; and
HEV-D comprised EV68 and EV70.1
A phylogenetic tree was constructed for 18 studied
strains of CA2. The tree was outgroup rooted using CA16
prototype G10 strain (U05876); EV71 strains (98-984-S3,
U22622, and U22521); and nine CA2 reference strains
(AY919539, AB162722, AB188506, AY421760, AB162720,
AB162721, AB119642, AB119643, and AB188507); it was
built using the neighbor-joining method and bootstrap
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268 C.-H. Hsu et al.topologies by MEGA Version 4.0.5 The genetic distance was
calculated by a pairwise estimation of percent divergence
among the sequences.
Statistical analysis
Continuous variables were analyzed by Student t test, and
categorical data were compared with c2 tests. Significance
was defined as p value less than 0.05. Data were collected
in a Microsoft Excel database and analyzed with SPSS soft-
ware for Windows (Release 15.0; SPSS, Inc., Chicago, IL,
USA).
Results
Serotypes of EVs
We found a total of 187 children with 208 EV isolates from
throat, anus, or CSF. The EV strains of 128 patients were
categorized into 10 serotypes initially after viral culture
and indirect immunofluorescent antibody staining, and the
other EV isolates from 47 patients underwent PCR and VP1
sequencing, but nine samples were lost before this inves-
tigation and three strains were untypable. Therefore,
a total of 16 serotypes, including CA2, CA4, CA6, CA10,
Echo3, and Echo25 were detected. Subsequently, we
analyzed the clinical and epidemiological features of 175
patients infected by 16 serotypes, and 172 patients with
complete profile entered final analysis. There were 101
patients infected by HEV-A and 71 patients infected by HEV-
B. Figure 1 shows the flowchart of the enrolled patients andTable 1 Demography, clinical entities, and medical care
of HEV-A and HEV-B
Demographic
characteristics
HEV-A
(nZ 101)
HEV-B
(nZ 71)
p
Age (yr)
Mean SD 3.4 2.8 4.8 4.2 0.04
Median (range) 2.6 (0.5e17.4) 4.4 (0.01e17.7)
Sex
Male 59 49
Female 42 22 0.21
Clinical manifestations
HFMD 56 0 <0.01
Herpangina 41 18 0.05
Aseptic meningitis 0 19 <0.01
Nonspecific illness 4 34 <0.01
Medical care
No hospitalization 72 38
Hospitalization 29 33 0.03
ICU care 3 0
HEV-A includes EV71, CA2, CA4, CA6, CA10, and CA16, and HEV-
B includes CB1, CB3, CB4, CB5, CA9, Echo3, Echo4, Echo6,
Echo25, and Echo30.
CAZ coxsackievirus A; CBZ coxsackievirus B; EVZ enter-
ovirus; HEVZ human enterovirus; HFMDZ handefootemouth
disease; ICUZ intensive care unit; SDZ standard deviation.their serotype distribution. EV71, CA16, and CB4 were the
major three isolated strains in NTUH laboratory in 2008.
Demography
Table 1 shows that the mean [standard deviation (SD)] age is
3.4 (2.8) years and the median age is 2.6 years, ranging from
0.5 years to 17.4 years in HEV-A group. In the HEV-B group, the
mean (SD) andmedian (range) ages are 4.8 (4.2) years and 4.4
(0.01e17.7) years. The age of the HEV-A group was signifi-
cantly lesser than that of the HEV-B group (pZ 0.04). The age
distribution of both groups (HEV-A and HEV-B) was mostly less
than7 years (83%), and 47%of the caseswere found in children
younger than 3 years. No significant gender difference was
found between these two groups. Among cases of HFMD, the
mean age between EV71 and non-EV71 groups is similar
(3.2 2.6 years vs. 3.9 2.2 years, pZ 0.15). In the group of
meningitis, the mean (SD) age was slightly greater in patients
of Echos than that in patients of coxsackieviruses (8.0 5.1
years vs. 4.6 4.5 years, pZ 0.13). Themean age and gender
of individuals who were excluded from final analysis showed
no difference in comparison with those of the enrolled
patients. Sixty percent of the EV cases were identified
between April and July, which was the same period of the
major peak of EV activity in Taiwan.Clinical entities among different serotypes
All patients with HFMD were infected by HEV-A. The leading
cause of HFMD was EV71 (70%) followed by CA16 (27%). The
mean age and gender between EV71 and non-EV71 patients
with HFMD were of similar distribution. Fifteen percent of
patients with EV71-related HFMD were afebrile at the time
of diagnosis. Encephalomyelitis presented in three patients
with EV71. All of them were diagnosed with febrile HFMD
and needed intensive care. Elective intubation, intravenous
immunoglobulin (1 g/kg) and milrinone were administered.
The first patient entered the stage of cardiopulmonary
failure, progressed to irreversible neurological damage,
and passed away. The second patient experienced cardio-
pulmonary failure 3 days after disease onset, regaining
consciousness with sequelae of psychomotor retardation,
and needed tube feeding because of dysphagia and
a tracheostomy because of failure from weaning ventilator.
The last patient presented conscious disturbance with
poliomyelitis-like syndrome and progressed to the stage of
cardiopulmonary failure 2 days later, but fully recovered
without subsequent limb weakness.
Herpangina was mostly caused by HEV-A (69.5%,
pZ 0.05), and the leading strains were CA2 (25%) and CA6
(17%). About 11% patients with EV71 manifested herpangina
clinically. Figure 2 shows that the phylogenetic tree of the
18 CA2 strains, drawn on the basis of the alignment of the
VP1 gene sequences, is considered homologous. These
isolates were close to the reference strain AY919539 from
America in 2005.
Diagnosis of aseptic meningitis was totally related to
HEV-B (p< 0.01), and most of it was caused by Echo30
(42%). Table 2 shows that CB1, CB4, CB5, CA9, and Echo6
were also isolated from patients with aseptic meningitis in
2008. All patients with aseptic meningitis recovered well
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and no long-term sequelae.
Nonspecific illnesses, including fever, viral exanthem,
URI, and LRI, were significantly associated with HEV-B
(p< 0.01). Echo4 (21%), CB4 (18%), and CA9 (18%) are the
most common strains. Two siblings who were first diagnosed
of flu-like illness were infected by Echo3. Respiratory tract
infection is the major presentationdaround 76% of all
nonspecific illnesses. All patients with EV-associated
respiratory tract infection are listed in Table 3. The A
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Figure 2. Phylogenetic tree constructed using viral structure pro
labeled A-1918 to A-3298 are CA2 strains isolated in National Taiw
prototype G10 strain (U05876); enterovirus 71 strains (98-984-S3, U
AB162722, AB188506, AY421760, AB162720, AB162721, AB119642, Acirculation strains causing respiratory tract infection
included CA2, CA6, CA10, CA16, CB1, CB4, CB5, CA9, Echo3,
and Echo4. Among children with airway infection, 22 (76%)
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B119643, and AB188507).
Table 2 Clinical entities among different serotypes and groups of enteroviruses
Clinical
manifestations
HEV-A HEV-B Total
EV71 CA2 CA4 CA6 CA10 CA16 CB1 CB3 CB4 CB5 CA9 Echo3 Echo4 Echo6 Echo25 Echo30
HFMD 39 1 1 15 56
Herpangina 5 15 4 10 4 3 4 1 9 2 1 1 59
Meningitis 2 2 2 3 2 8 19
Nonspecific illness 1 1 1 1 4 7 2 7 5 8 1 38
CAZ coxsackievirus A; CBZ coxsackievirus B; EchoZ echovirus; EVZ enterovirus; HEVZ human enterovirus.
270 C.-H. Hsu et al.Other bacterial or atypical pathogens were not detected
with EV infection.
Factors associated with hospitalization
The hospitalization rate by individual diagnosis was as
follows: 29% in HFMD; 27% in herpangina; 100% in aseptic
meningitis; and 29% in nonspecific illnesses, including 100%
of LRI.
The overall hospitalization rates of HEV-A and HEV-B
groups were 31% and 46%, respectively (pZ 0.03). Patients
with HFMD who were infected by EV71 had more demand
for hospitalization than those who were infected by other
strains in HEV-A, but the hospitalization rate was not
statistically significant (33% vs. 18%, pZ 0.38).
Figure 3 shows the age distribution and individual
hospitalization numbers of HEV-A and HEV-B groups. The
peak age of inpatients in the HEV-A group was between 1
year and 2 years, and 76% of the inpatients were younger
than 6 years. In the hospitalized patients of HEV-B group,
the major peak was less than 1 year (36%) and the minor
peak was 6e8 years (24%).
The multivariate analysis in Table 4 shows the association
between serogroup and hospitalization. HEV-B was a signifi-
cant risk factor for hospitalization after age was adjusted
(odds ratio, 2.2; 95% confidence interval, 1.1e4.2, pZ 0.02).Discussion
This study presents NPEV infections in one medical center
in northern Taiwan in 2008. During this same epidemicTable 3 Clinical diagnosis and virological features of 29 pediat
Diagnosis No.
of patients
Mean age
(yr)
Male/female
Tonsillitis 12 5.4  3.0 10/2
Rhinopharyngitis 10 5.1  3.9 5/5
Bronchiolitis 4 0.8  0.5 2/2
Bronchopneumonia 3 4.6  4.9 3/0
Total 29 4.6  3.7 20/9
a RSV infection was diagnosed by sputum antigen test.
Data are presented as n, n(%) or mean  standard deviation. RSVZ rperiod, at least 16 serotypes of EVs circulated in the
community of northern Taiwan, and EV71 and CA16
ranked as the Top 2. The most common clinical presen-
tations are still HFMD and herpangina. We found that all
patients with HFMD were infected by HEV-A, but HEV-B
was associated with a higher rate of hospitalization and
aseptic meningitis.
The EV surveillance result between 2000 and 2008 from
CDC, Taiwan shows that the ranking of EV71 had slipped
down after 2005 until the epidemic recurred in 2008.3,6 It is
supposed that the seropositivity rate was decreasing with
years in the population, especially among the infants and
toddlers who are most susceptible to EV infections.6,7 We
speculate that the accumulation of the susceptible hosts
during the past few years may explain the occurrence of
EV71 outbreak in 2008.
The case numbers of EV71 are far more than those of
CA2 strains in NTUH, and this result is different from the
ranking data of EVs from CDC-TW in the same period, which
showed that CA2 was the top one. This might be related to
different patient characteristics in NTUH and in local
hospitals or clinics because more severe cases or HFMD
cases tended to seek medical care in medical centers
rather than local hospitals or clinics. In this study, most of
the patients presented with HFMD, which was known as the
most common presentation of EV71 and the common
preceding syndrome of severe EV cases with central
nervous system (CNS) involvement in Taiwan.8
We select CA2 for phylogenic analysis because it takes
the first place in whole-country surveillance of NPEV
infection in 2008. CA2 is known as a less important strain for
HEV outbreaks in Taiwan after 1998.6 In addition to theric patients with an enterovirus-related respiratory infection
Multiple
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RSV (2)a 3 (100) Echo4 (3)
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Figure 3. Age distribution and medical care of HEV-A and HEV-B. HEVZ human enterovirus.
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circulation in environment may represent a problem of
public health. The recent survey of EVs in environmental
water and hot spring water showed CA2 to be a dominant
serotype in Taiwan.9,10 We suspect that CA2 may circulate
in the environment and, thus, play some role in the
outbreak of 2008.
Some symptoms are particularly characteristic of certain
serotypes, such as HFMD of EV71 and CA16, and aseptic
meningitis of Echos.11 Herpangina is usually related to HEV-A
rather than HEV-B. In a recent report, all the serotypes
accounting for herpangina in the annual epidemic data of
Japan show CA.12 The serotype distribution of herpangina in
our result is compatible with that in Taiwan during
2000e2005.6 Echos and coxsackieviruses are known as the
dominant pathogens of pediatric aseptic meningitis, and
outbreaks of Echo30 infection are frequently discussed in
Europe, South America, and Asia.6,13 Although coxsack-
ieviruses caused fewer outbreaks in history, the clinical
entities are not significantly different from those of
echoviruses.
EV-related respiratory tract infection was analyzed to
a lesser extent in previous reports. Our understanding of the
epidemiology and clinical profile of EV-related respiratory
infection is mostly from the surveillance of respiratory viral
infections. The average rate of positive EV isolation for
pediatric respiratory infections in Taiwan ranged from 12.7%Table 4 Multivariate analysis of factors associated with
hospitalization
Parameter OR (95% CI) p
Age, yr 3 vs. ＞3 1.7 (0.9e3.3) 0.12
Sex male vs. female 1.8 (0.9e3.5) 0.11
Species HEV-B vs. HEV-A 2.2 (1.1e4.2) 0.02
Serotypes(non-EV71 vs. EV71) 1.2 (0.6e2.6) 0.57
CIZ confidence interval; EVZ enterovirus; HEVZ human
enterovirus; ORZ odds ratio.to 22%.14,15 A Japanese analysis of respiratory viruses from
children in 2004 and 2005 displayed an approximate positive
EV rate of 20% among children with acute respiratory infec-
tions. Another comprehensive retrospective study in France
that reviewed a pediatric cohort from 1999 to 2005 gave the
positive EV rate of 11.6%.16 Other countries showed a lower
rate of about 0.2e5.7% in Singapore, Czechoslovakia, Brazil,
and United States.17e20 The seasonal distribution in France
revealed a greater case number during springefall season
and a peak in June to July.16
Till date, it is unclear which are the dominant serotypes
or groups in airway infections.16,17,21,22 CB3, CB5, and
Echo20 were addressed to be related to the so-called
“summer grippe” or common cold.23 CA2, CA4e6, CA10,
CB1, CB2, and CB5, and Echo9, Echo18, and Echo30 had also
been isolated or identified from children with acute
tonsillitis in earlier studies.24,25 There might be a trend that
HEV-B is the dominant group in patients with acute respi-
ratory infections, but there is no detailed control study to
support this. Another concern is whether EVs are true
pathogens or an incidental colonization in airway infec-
tions. A study of nasopharynx colonization in children
showed that EV RNA may be detected among asymptomatic
children, although previous respiratory symptoms or
contact with symptomatic family members can be traced.26
Another article reported that EV RNA may disappear in
nasal cavity about 2e5 weeks after acute respiratory
infection.27 This might indicate that colonization is
possible, and EV-related respiratory infections might be
overestimated. In our study, five patients were detected
with concomitant Echo4 and RSV at the same time. Raw-
linson et al.28 studied the relationship between viruses in
nasopharynx and acute exacerbation of asthma and found
EVs from nasopharyngeal aspiration (NPA) in 29% of children
with asthma in the summer. Jartti et al.29 described mixed
viral infections, mostly RSV and EV (19%), from NPA, in
a prospective clinical trial for children with acute expira-
tory wheezing. Because analysis of pathogens of all respi-
ratory tract infections by throat swab or NPA might be
misinterpreted by concurrent acute infection, further
272 C.-H. Hsu et al.surveillance of the EV prevalence in healthy controls may
be needed.
EV71 can result in disability or even death; hence, risk
factors of EV71-related CNS involvement have been clini-
cally focused after the outbreak occurred in Taiwan in
1998. Young age, especially less than 3 years, is the most
important risk factor of the unfavorable outcome in chil-
dren.30 Our study chooses hospitalization as an indicator of
disease severity because the clinical management cannot
be interfered in the retrospective review. After adjusting
for age and gender, it is interesting to note that the
hospitalization rate of non-EV71 infection is not lower than
that of EV71 infection. The first-line physicians enforced an
effective screening by stage-based management, which can
primarily differentiate patients with and without the
potential risk of CNS involvement and cardiopulmonary
failure.31 Patients infected by HEV-B might be more toxic
and show the need for inpatient care at the time of medical
visit. The major diagnoses, aseptic meningitis and LRI, were
reasonable to present toxic appearance initially. This issue
proves that EVs other than EV71 may be a burden on public
health, especially on the cost of health insurance. Our
study is limited by the short period, single medical center,
and the retrospective nature. However, it still represents
a regional epidemiology in the outbreak of 2008.
In conclusion, we found at least 16 serotypes that
circulated in northern Taiwan in 2008. EV71 is back to be
the predominant strain in this outbreak. Clinically, HEV-B
group is associated with a higher rate of hospitalization and
aseptic meningitis, compared with HEV-A, which should be
a cause of alertness regarding public health.
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